Search for:

In brief

The Ministry of Health (MOH) is conducting a public consultation from 11 December 2023 to 11 January 2024 on the proposed Health Information Bill (HIB).

Through the HIB, the MOH intends to establish a framework governing the safe collection, use and sharing of health information across Singapore’s healthcare ecosystem to facilitate better continuity and seamless transition of care.


Contents

  1. Background
  2. Main objectives of the HIB
  3. Enforcement of the HIB

Background

During the parliamentary debates on the White Paper on Healthier SG, the MOH raised that one of the key tools for successfully implementing Healthier SG is the National Electronic Health Record (NEHR), a central repository of patient summary health records. The NEHR is intended to establish a network between public and private healthcare institutions to improve the flow of data across the healthcare ecosystem.

To facilitate the proper collection, use and sharing of health data among healthcare providers in a safe and secure manner through the NEHR, the MOH announced its intention to introduce the HIB in 2023.

Further background is set out in our previous client alert of March 2023.

Main objectives of the HIB

The HIB serves to fulfill three main objectives.

1. Ensure that health information is kept updated, accurate and accessible

It will be mandatory for all licensed healthcare providers and approved contributors to contribute patient health data to the NEHR.

Access to a patient’s summary medical records will be provided to licensed healthcare providers and approved users.

This facilitates more coordinated, efficient and appropriate care as patients will not need to repeat their medical history to different healthcare providers or go for repetitive health tests, ultimately saving time and costs.

2. Establish a robust framework for sharing health information

The HIB aims to simplify the health data sharing framework and set out the boundaries of data sharing.

For care transition to be made as seamless as possible, the NEHR should only contain accurate and up-to-date key health information of the patients and be shared with necessary healthcare providers.

Under the HIB, the MOH will set out the types of information that healthcare providers must contribute and the individuals to which the requirement will apply (e.g., health information of short-term visit pass holders will not be required as they are transient residents). Categories of key health information include patient demographics, visits, medical diagnosis, allergies, operating theater notes, discharge summaries, medications and investigation reports.

Further, sensitive health information will be subject to additional access requirements and therefore not be readily accessible compared to other key health information. Sensitive health information is information that risks subjecting individuals to discrimination or social stigma, such as sexually transmitted diseases, schizophrenia, substance abuse and addiction, etc.

The purposes for which the data from the NEHR may be used will also be set out clearly, and individuals can place access restrictions on the sharing of their health data.

Shared health information would improve the efficiency and quality of patient care and support continuity of care for patients moving between primary or specialist care and acute and community care providers.

3. Set out data security and cybersecurity requirements that healthcare providers must comply with

Healthcare providers contributing to or accessing the NEHR will have to comply with data security and cybersecurity requirements set out in the HIB.

These requirements build on existing data security and cybersecurity guidelines and standards, such as the MOH’s Healthcare Cybersecurity Essentials Guidelines.

Healthcare providers will be required to report cybersecurity incidents or data breaches that meet prescribed thresholds to the MOH within two hours upon confirmation that the incident is notifiable. This allows the MOH to take prompt action to limit the impact to patient safety and privacy, and detect early patterns that signal a larger-scale attack. There will also be notification requirements to affected individuals.

This set of data security and cybersecurity measures ensures protection of patient privacy and guards against any leakage of health information.

Enforcement of the HIB

To ensure that the HIB requirements are complied with and noncompliance is dealt with swiftly and appropriately, the MOH will have powers under the HIB to issue directions for entities to rectify breaches of the HIB, such as stopping unauthorized access to health information on the NEHR, destroying all health information collected in an unauthorized manner, stopping further unauthorized sharing of health information under the data sharing framework, and strict compliance with cyber and data security requirements.

Additionally, the MOH will also have emergency powers to perform remediation measures in severe situations. There will be a penalty framework aligned to other applicable legislation, and fines of up to SGD 1 million or 10% of the organization’s annual turnover (whichever is higher) may be imposed for severe noncompliance.

* * * * *

From 11 December 2023 to 11 January 2024, members of the public, patients, healthcare providers and data intermediaries can submit their feedback through the HIB consultation form.

Author

Andy Leck is the head of the Intellectual Property and Technology (IPTech) Practice Group and a member of the Dispute Resolution Practice Group in Singapore. He is a core member of Baker McKenzie's regional IP practice and also leads the Myanmar IP Practice Group. Andy is recognised by reputable global industry and legal publications as a leader in his field. He was named on "The A-List: Singapore's Top 100 lawyers" by Asia Business Law Journal 2018. In addition, Chambers Asia Pacific notes that Andy is "a well-known IP practitioner who is highlighted for his record of handling major trade mark litigation, as well as commercial exploitation of IP rights in the media and technology sectors. He's been in the industry for a long time and has always been held in high regard. He is known to be very fair and is someone you would like to be in the trenches with you during negotiations." Furthermore, Asian Legal Business acknowledges Andy as a leading practitioner in his field and notes that he “always gives good, quick advice, [is] client-focused and has strong technical knowledge for his areas of practice.” Andy was appointed by the Intellectual Property Office of Singapore (IPOS) as an IP Adjudicator to hear disputes at IPOS for a two-year term from April 2021. He has been an appointed member of the Singapore Copyright Tribunal since May 2010 and a mediator with the WIPO Arbitration and Mediation Center. He is also appointed as a Notary Public & Commissioner for Oaths in Singapore. He previously served on the International Trademark Association’s Board of Directors and was a member of the executive committee.

Author

Ren Jun Lim is a principal with Baker McKenzie Wong & Leow. He represents local and international clients in both contentious and non-contentious intellectual property matters. He also advises on a full range of healthcare, as well as consumer goods-related legal and regulatory issues. Ren Jun co-leads Baker McKenzie Wong & Leow's Healthcare as well as Consumer Goods & Retail industry groups. He sits on the Law Society of Singapore IP Committee and on the Executive Committee of the Association of Information Security Professionals. He is also a member of the Vaccines Working Group, Singapore Association of Pharmaceutical Industries, a member of the International Trademark Association, as well as a member of the Regulatory Affairs Professionals Association. Ren Jun is ranked in the Silver tier for Individuals: Enforcement and Litigation and Individuals: Prosecution and Strategy, and a recommended lawyer for Individuals: Transactions by WTR 1000, 2020. He is also listed in Asia IP's Best 50 IP Expert, 2020, recognised as a Rising Star by Managing IP: IP Stars, 2019 and one of Singapore's 70 most influential lawyers aged 40 and under by Singapore Business Review, 2016. Ren Jun was acknowledged by WTR 1000 as a "trademark connoisseur who boasts supplementary knowledge of regulatory issues in the consumer products industry." He was also commended by clients for being "very responsive to enquiries and with a keen eye for detail, he is extremely hands-on. His meticulous and in-depth approach to strategising is key to the excellent outcomes we enjoy."

Write A Comment